Citations

Showing 10 of 108060 citations.

Septal Ablation and Hypertrophic Obstructive Cardiomyopathy: 7 Years US Experience
Chothani, Ankit , Panaich, Sidakpal , Patel, Nilay , Patel, Nileshkumar , Arora, Shilpkumar , Deshmukh, Abhishek , Badheka, Apurva O., Grines, Cindy L. , Panaich, Sidakpal S

Mayo Clinic

Journal of Interventional Cardiology | August 22, 2016 | Volume: 29 | Issue: 5 | Pages: 505-512

10.1111/joic.12319 | PMID 27545515 Get It

BackgroundSeptal ablation (SA) is a key modality for left ventricular outflow tract gradient reduction in hypertrophic obstructive cardiomyopathy (HOCM) patients with refractory symptoms. The primary objective of our study was to evaluate post‐procedural mortality, complications, length of stay (LOS), and cost of hospitalization following SA.MethodsWe queried the Nationwide Inpatient Sample (NIS) between 2005 and 2011 using the ICD9 procedure code of 37.34 for ablation of heart tissue. Only adult patients with HOCM (ICD‐9‐CM: 425.1) were included. Patients with any arrhythmia diagnosis or open surgical ablation procedure code were excluded. Hierarchical mixed effects models were generated in order to identify the independent multivariate predictors of outcomes.ResultsA total of 358 SAs were available for analysis. There was no reported mortality during the study period; permanent pacemaker implantation rate was 8.7%. Highest hospital volume tertile (OR, 95%CI, P‐ value) predicted significantly lower post‐procedural complications (0.51, 0.26–0.98, P = 0.04). Univariate analysis of highest versus lowest tertile of hospital volume showed significant decrease in LOS (2.6 days vs. 3.8 days, P<0.01) and non‐significant decrease hospitalization costs (16,800$ vs. 19,500$, P = 0.29).ConclusionsSA is a safe procedure and associated with low peri‐ procedural mortality rate. A higher burden of baseline comorbidities is associated with worse outcomes while higher annual hospital volume is associated with lower rate of post‐procedural complications, length of stay, and cost of care following SA.
Ultrasonic bone aspirator (Sonopet) for meatal bone removal during retrosigmoid craniotomy for vestibular schwannoma
Modest, Mara C., Carlson, Matthew L. , Link, Michael J. , Driscoll, Colin L. W.

Mayo Clinic

The Laryngoscope | August 22, 2016 | Volume: 127 | Issue: 4 | Pages: 805-808

10.1002/lary.26219 | PMID 27546602 Get It

A comparison of infarct mass by cardiac magnetic resonance and real time myocardial perfusion echocardiography as predictors of major adverse cardiac events following reperfusion for ST elevation myocardial infarction
Lenz, Charles J., Anavekar, Nandan S., Foley, Thomas A. , Nhola, Lara F., Huang, Runqing, Oh, Jae K. , Abdelmoneim, Sahar S. , Mulvagh, Sharon L.

Mayo Clinic

Echocardiography | August 22, 2016 | Volume: 33 | Issue: 10 | Pages: 1539-1545

10.1111/echo.13308 | PMID 27546353 Get It

PurposeInfarct mass as assessed by myocardial‐delayed enhancement imaging on cardiac magnetic resonance (CMR) and myocardial blood flow as assessed by real time myocardial perfusion echocardiography (RT‐MPE) have been shown to predict adverse events following ST elevation myocardial infarction (STEMI). There has been no published comparison of quantitative assessment using these modalities as predictors of clinical outcomes to date. We compared RT‐MPE with CMR for prediction of cardiac events in reperfused STEMI patients.Materials and MethodsConsecutive STEMI patients with early reperfusion were studied. RT‐MPE and CMR were performed. Perfusion score indices (PSIRT‐MPE and PSICMR) were calculated [sum of segmental perfusion scores/number of segments]. CMR infarct mass (g) and RT‐MPE myocardial blood flow (MBF dB/s) were quantified. Patients were followed for cardiac events (death, nonfatal MI, revascularization, angina, and heart failure).ResultsAll 27 patients (age 62±14; follow‐up 3.5±2.6 years) had thrombolysis in myocardial infarction (TIMI) grade 3 flow of infarct vessel. Cardiac events occurred in 17 (63%). Cardiac event patients had higher PSIRT‐MPE, PSICMR, infarct mass, and lower MBF. PSIRT‐MPE cutoff of 0.3 had an AUC of 0.856 (82% sensitivity, 70% specificity), while a PSICMR cutoff of 0.2 had an AUC of 0.765 (76% sensitivity, 60% specificity). Infarct mass and MBF were independent predictors of cardiac events after adjusting for risk factors (hazard ratios: 20.9 [95% CI 1.8–256] P=.02 and 8.1 [95% CI 1.5–78] P=.01, respectively).ConclusionsQuantitative RT‐MPE performed comparably to CMR for prediction of MACE in STEMI patients supporting a prognostic role for this noninvasive, bedside imaging method.
Sudden cardiac death and late arrhythmias after the Fontan operation
Pundi, Kavitha N., Pundi, Krishna , Johnson, Jonathan N. , Driscoll, David J. , Wackel, Philip L. , Cetta, Frank , Cannon, Bryan C. , Li, Zhuo , Pundi, Krishna N, Dearani, Joseph A. , Li, Zhuo Ya , McLeod, Christopher J. , Pundi, Krishna

Mayo Clinic

Congenital Heart Disease | August 22, 2016 | Volume: 12 | Issue: 1 | Pages: 17-23

10.1111/chd.12401 | PMID 27545004 Get It

Reliability of Triaxial Accelerometry for Measuring Load in Men's Collegiate Ice Hockey
Iterson, Erik H. Van , Fitzgerald, John S. , Dietz, Calvin C., Snyder, Eric M., Peterson, Ben , Van Iterson, Erik H, Van Iterson, Erik H

Mayo Clinic

Journal of Strength and Conditioning Research | August 20, 2016 | Volume: 31 | Issue: 5 | Pages: 1305-1312

10.1519/jsc.0000000000001611 | PMID 27548782 Get It

Abstract Van Iterson, EH, Fitzgerald, JS, Dietz, CC, Snyder, EM, and Peterson, BJ. Reliability of triaxial accelerometry for measuring load in men's collegiate ice hockey. J Strength Cond Res 31(5): 1305–1312, 2017—Wearable microsensor technology incorporating triaxial accelerometry is used to quantify an index of mechanical stress associated with sport-specific movements termed PlayerLoad. The test-retest reliability of PlayerLoad in the environmental setting of ice hockey is unknown. The primary aim of this study was to quantify the test-retest reliability of PlayerLoad in ice hockey players during performance of tasks simulating game conditions. Division I collegiate male ice hockey players ( N = 8) wore Catapult Optimeye S5 monitors during repeat performance of 9 ice hockey tasks simulating game conditions. Ordered ice hockey tasks during repeated bouts included acceleration (forward or backward), 60% top-speed, top-speed (forward or backward), repeated shift circuit, ice coasting, slap shot, and bench sitting. Coefficient of variation (CV), intraclass correlation coefficient (ICC), and minimum difference (MD) were used to assess PlayerLoad reliability. Test-retest CVs and ICCs of PlayerLoad were as follows: 8.6% and 0.54 for forward acceleration, 13.8% and 0.78 for backward acceleration, 2.2% and 0.96 for 60% top-speed, 7.5% and 0.79 for forward top-speed, 2.8% and 0.96 for backward top-speed, 26.6% and 0.95 for repeated shift test, 3.9% and 0.68 for slap shot, 3.7% and 0.98 for coasting, and 4.1% and 0.98 for bench sitting, respectively. Raw differences between bouts were not significant for ice hockey tasks ( p > 0.05). For each task, between-bout raw differences were lower vs. MD: 0.06 vs. 0.35 (forward acceleration), 0.07 vs. 0.36 (backward acceleration), 0.00 vs. 0.06 (60% top-speed), 0.03 vs. 0.20 (forward top-speed), 0.02 vs. 0.09 (backward top-speed), 0.18 vs. 0.64 (repeated shift test), 0.02 vs. 0.10 (slap shot), 0.00 vs. 0.10 (coasting), and 0.01 vs. 0.11 (bench sitting), respectively. These data suggest that PlayerLoad demonstrates moderate-to-large test-retest reliability in the environmental setting of male Division I collegiate ice hockey. Without previously testing reliability, these data are important as PlayerLoad is routinely quantified in male collegiate ice hockey to assess on ice physical activity.
Occupational musculoskeletal pain in cardiac sonographers compared to peer employees: a multisite cross‐sectional study
Orme, Nicholas M., Geske, Jeffrey B. , Pislaru, Sorin V. , Askew, J. Wells , Lennon, Ryan J. , Lewis, Bradley R., Rihal, Charanjit S. , Pellikka, Patricia A. , Singh, Mandeep , Askew, John Wells, Lennon, Ryan J. , Rihal, Charanjit S. , Sabbah, Michael S. , Pellikka, Patricia A , Geske, Jeffrey B

Mayo Clinic

Echocardiography | August 20, 2016 | Volume: 33 | Issue: 11 | Pages: 1642-1647

10.1111/echo.13344 | PMID 27542567 Get It

ObjectivesThe purpose of this study was to compare the prevalence and impact of work‐related musculoskeletal pain in cardiac sonographers to a large control group of peer employees with similar demographics.BackgroundCardiac sonographers are known to have high levels of occupational musculoskeletal pain. Comparative studies with other employees within cardiology/radiology departments have never been performed.MethodsAn electronic survey was administered to Mayo Clinic employees at six major patient care facilities in four different states.ResultsThere were 2682 employees within the departments of cardiology and radiology who were contacted, and 1532 (57%) completed the survey. After excluding those who wore protective lead aprons, 517 employees comprised the control group and 66 cardiac sonographers made up the study group. Cardiac sonographers reported work‐related musculoskeletal pain more frequently than the control group (88% vs 40%; P<.001). This association persisted after multivariable adjustment for age, sex, body mass index, length of current employment, and history of preexisting musculoskeletal pain (OR 11.6; [95% CI 5.32, 25.5]; P<.001). Cardiac sonographers sought medical care for their work‐related pain more often (55% vs 21%; P<.001) and missed more work due to pain (35% vs 12%, P<.001). In a secondary analysis, cardiac sonographers also experienced more work‐related musculoskeletal pain than nurses, technicians, and physicians working in the interventional laboratory who regularly wear a protective lead apron (P<.001).ConclusionsIn this multisite cross‐sectional study, cardiac sonographers experienced significantly more work‐related pain and missed more work due to pain than peer employees within cardiology/radiology departments.
Ion Channel Remodeling—A Potential Mechanism Linking Sleep Apnea and Sudden Cardiac Death
Chahal, C. Anwar A. , Chahal, Anwar Ahmed, Somers, Virend K. , Chahal, Choudhary Anwar A

Mayo Clinic

Journal of the American Heart Association | August 20, 2016 | Volume: 5 | Issue: 8 | Pages: No page available

10.1161/jaha.116.004195 | PMID 27543309 Get It

First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis
Sher, Taimur , Fenton, Brooke, Akhtar, Adnan, Gertz, Morie A.

Mayo Clinic

Blood | August 20, 2016 | Volume: 128 | Issue: 15 | Pages: 1987-1989

10.1182/blood-2016-06-722496 | PMID 27543437 Get It

Prevalence of suicidal behaviour following traumatic brain injury: Longitudinal follow-up data from the NIDRR Traumatic Brain Injury Model Systems
Fisher, Lauren , Pedrelli, Paola , Iverson, Grant L. , Bergquist, Thomas F. , Bombardier, Charles H. , Hammond, Flora M., Hart, Tessa , Ketchum, Jessica M. , Zafonte, Ross , Giacino, Joseph T. , Bombardier, Charles

Mayo Clinic

Brain Injury | August 19, 2016 | Volume: 30 | Issue: 11 | Pages: 1311-1318

10.1080/02699052.2016.1195517 | PMID 27541868 Get It

Comparison of Collection Methods for Fecal Samples for Discovery Metabolomics in Epidemiologic Studies
Loftfield, Erikka , Vogtmann, Emily , Moore, Steven C. , Nelson, Heidi , Knight, Rob , Chia, Nicholas , Sampson, Joshua N. , Chia, Nicholas , Sinha, Rashmi R. , Moore, Steven C

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | August 19, 2016 | Volume: 25 | Issue: 11 | Pages: 1483-1490

10.1158/1055-9965.epi-16-0409 | PMID 27543620 Get It

Abstract Background: The gut metabolome may be associated with the incidence and progression of numerous diseases. The composition of the gut metabolome can be captured by measuring metabolite levels in the feces. However, there are little data describing the effect of fecal sample collection methods on metabolomic measures. Methods: We collected fecal samples from 18 volunteers using four methods: no solution, 95% ethanol, fecal occult blood test (FOBT) cards, and fecal immunochemical test (FIT). One set of samples was frozen after collection (day 0), and for 95% ethanol, FOBT, and FIT, a second set was frozen after 96 hours at room temperature. We evaluated (i) technical reproducibility within sample replicates, (ii) stability after 96 hours at room temperature for 95% ethanol, FOBT, and FIT, and (iii) concordance of metabolite measures with the putative “gold standard,” day 0 samples without solution. Results: Intraclass correlation coefficients (ICC) estimating technical reproducibility were high for replicate samples for each collection method. ICCs estimating stability at room temperature were high for 95% ethanol and FOBT (median ICC &gt; 0.87) but not FIT (median ICC = 0.52). Similarly, Spearman correlation coefficients (rs) estimating metabolite concordance with the “gold standard” were higher for 95% ethanol (median rs = 0.82) and FOBT (median rs = 0.70) than for FIT (median rs = 0.40). Conclusions: Metabolomic measurements appear reproducible and stable in fecal samples collected with 95% ethanol or FOBT. Concordance with the “gold standard” is highest with 95% ethanol and acceptable with FOBT. Impact: Future epidemiologic studies should collect feces using 95% ethanol or FOBT if interested in studying fecal metabolomics. Cancer Epidemiol Biomarkers Prev; 25(11); 1483–90. ©2016 AACR.